Boston Scientific Shares Outstanding 2010-2025 | BSX

Boston Scientific shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Boston Scientific shares outstanding for the quarter ending March 31, 2025 were 1.493B, a 0.77% increase year-over-year.
  • Boston Scientific 2024 shares outstanding were 1.486B, a 1.53% increase from 2023.
  • Boston Scientific 2023 shares outstanding were 1.464B, a 1.65% increase from 2022.
  • Boston Scientific 2022 shares outstanding were 1.44B, a 0.41% increase from 2021.
Boston Scientific Annual Shares Outstanding
(Millions of Shares)
2024 1,486
2023 1,464
2022 1,440
2021 1,434
2020 1,417
2019 1,411
2018 1,401
2017 1,393
2016 1,377
2015 1,341
2014 1,324
2013 1,341
2012 1,407
2011 1,519
2010 1,518
2009 1,508
Boston Scientific Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 1,493
2024-12-31 1,486
2024-09-30 1,487
2024-06-30 1,484
2024-03-31 1,482
2023-12-31 1,464
2023-09-30 1,475
2023-06-30 1,456
2023-03-31 1,446
2022-12-31 1,440
2022-09-30 1,440
2022-06-30 1,438
2022-03-31 1,438
2021-12-31 1,434
2021-09-30 1,436
2021-06-30 1,433
2021-03-31 1,431
2020-12-31 1,417
2020-09-30 1,431
2020-06-30 1,411
2020-03-31 1,414
2019-12-31 1,411
2019-09-30 1,412
2019-06-30 1,409
2019-03-31 1,408
2018-12-31 1,401
2018-09-30 1,404
2018-06-30 1,399
2018-03-31 1,397
2017-12-31 1,393
2017-09-30 1,394
2017-06-30 1,391
2017-03-31 1,390
2016-12-31 1,377
2016-09-30 1,380
2016-06-30 1,357
2016-03-31 1,370
2015-12-31 1,341
2015-09-30 1,344
2015-06-30 1,362
2015-03-31 1,334
2014-12-31 1,324
2014-09-30 1,348
2014-06-30 1,345
2014-03-31 1,349
2013-12-31 1,341
2013-09-30 1,340
2013-06-30 1,359
2013-03-31 1,352
2012-12-31 1,407
2012-09-30 1,393
2012-06-30 1,423
2012-03-31 1,454
2011-12-31 1,519
2011-09-30 1,524
2011-06-30 1,536
2011-03-31 1,536
2010-12-31 1,518
2010-09-30 1,529
2010-06-30 1,525
2010-03-31 1,515
2009-12-31 1,508
2009-09-30 1,509
2009-06-30 1,515
2009-03-31 1,505
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $147.057B $16.747B
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.365B 28.30
Stryker (SYK) United States $145.454B 30.41
EssilorLuxottica (ESLOY) France $130.907B 0.00
Medtronic (MDT) Ireland $112.941B 16.01
Lonza Group Ag (LZAGY) Switzerland $50.659B 0.00
Haleon (HLN) United Kingdom $49.106B 27.97
ResMed (RMD) United States $36.856B 27.68
Agilent Technologies (A) United States $34.008B 22.17
GE HealthCare Technologies (GEHC) United States $33.609B 15.96
Terumo (TRUMY) Japan $26.946B 35.00
Koninklijke Philips (PHG) Netherlands $22.201B 15.96
Insulet (PODD) United States $21.270B 83.49
Zimmer Biomet Holdings (ZBH) United States $18.645B 11.98
Baxter (BAX) United States $16.114B 12.03
Smith & Nephew SNATS (SNN) United Kingdom $13.196B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.264B 21.80
Lantheus Holdings (LNTH) United States $5.587B 14.09
Prestige Consumer Healthcare (PBH) United States $4.206B 18.79
Perrigo (PRGO) Ireland $3.763B 9.54
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.435B 15.65
ICU Medical (ICUI) United States $3.309B 24.40
Envista Holdings (NVST) United States $3.259B 27.08
GN Store Nord (GNNDY) Denmark $2.362B 19.57
QuidelOrtho (QDEL) United States $2.094B 14.40
LeMaitre Vascular (LMAT) United States $1.878B 41.99
AtriCure (ATRC) United States $1.635B 0.00
Acuren (TIC) United States $1.305B 0.00
Neogen (NEOG) United States $1.238B 15.85
AdaptHealth (AHCO) United States $1.181B 11.99
BioLife Solutions (BLFS) United States $1.128B 0.00
Green Thumb Industries (GTBIF) United States $1.075B 24.19
Kestra Medical Technologies (KMTS) United States $1.001B 0.00
Phibro Animal Health (PAHC) United States $0.989B 12.64
InMode (INMD) Israel $0.903B 9.10
Evolus (EOLS) United States $0.660B 0.00
CeriBell (CBLL) United States $0.642B 0.00
Owens & Minor (OMI) United States $0.606B 5.03
Capricor Therapeutics (CAPR) United States $0.600B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.581B 0.00
Curaleaf Holdings (CURLF) Canada $0.554B 0.00
Valneva SE (VALN) France $0.534B 0.00
Tilray Brands (TLRY) Canada $0.429B 0.00
Surmodics (SRDX) United States $0.415B 0.00
VAREX IMAGING (VREX) United States $0.359B 13.21
SNDL (SNDL) Canada $0.349B 0.00
Aurora Cannabis (ACB) Canada $0.340B 60.40
Canopy Growth (CGC) Canada $0.289B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.283B 0.00
Cerus (CERS) United States $0.271B 0.00
Sanuwave Health (SNWV) United States $0.268B 0.00
Viemed Healthcare (VMD) United States $0.267B 22.50
ZimVie (ZIMV) United States $0.265B 12.06
Cresco Labs (CRLBF) United States $0.261B 0.00
Quanterix (QTRX) United States $0.259B 0.00
Sanara MedTech (SMTI) United States $0.257B 0.00
Brainsway (BWAY) Israel $0.222B 58.65
Biote (BTMD) United States $0.220B 6.18
OraSure Technologies (OSUR) United States $0.218B 0.00
Omeros (OMER) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.199B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.185B 15.09
Verano Holdings (VRNOF) United States $0.183B 0.00
Exagen (XGN) United States $0.155B 0.00
Vireo Growth (VREOF) United States $0.141B 0.00
FitLife Brands (FTLF) United States $0.130B 16.05
Jin Medical (ZJYL) China $0.108B 0.00
MacroGenics (MGNX) United States $0.108B 0.00
Veru (VERU) United States $0.099B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.61
TerrAscend (TSNDF) Canada $0.078B 0.00
Agape ATP (ATPC) $0.078B 0.00
InterCure (INCR) Israel $0.071B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Apyx Medical (APYX) United States $0.067B 0.00
Zynex (ZYXI) United States $0.062B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.047B 0.00
Nephros (NEPH) United States $0.040B 54.21
United-Guardian (UG) United States $0.038B 13.18
Rockwell Medical (RMTI) United States $0.034B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
INLIF (INLF) $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00